Cargando…

Blood B Cell and Regulatory Subset Content in Multiple Sclerosis Patients

OBJECTIVE: B cell targeted therapies have been effective in slowing multiple sclerosis (MS) disease progression suggesting a direct causal link for this lymphoid subset. A small subset of B cells with regulative properties (Bregs) exists in peripheral blood, and induction of Bregs ameliorates experi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habib, Jakob, Deng, Jiusheng, Lava, Neil, Tyor, William, Galipeau, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484600/ https://www.ncbi.nlm.nih.gov/pubmed/26137596 http://dx.doi.org/10.4172/2376-0389.1000139

Ejemplares similares

Maltose-Binding Protein Fusion Allows for High Level Bacterial Expression and Purification of Bioactive Mammalian Cytokine Derivatives
por: Pennati, Andrea, et al.
Publicado: (2014)

GIFT4-augmented B cells for melanoma immunotherapy
por: Deng, Jiusheng, et al.
Publicado: (2014)

Immune responses to SARS‐CoV‐2 vaccination in multiple sclerosis: a systematic review/meta‐analysis
por: Gombolay, Grace Y., et al.
Publicado: (2022)

CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
por: Hu, William T., et al.
Publicado: (2019)

GIFT4 fusokine converts leukemic B cells into immune helper cells
por: Deng, Jiusheng, et al.
Publicado: (2016)

Regulatory Cells in Multiple Sclerosis: From Blood to Brain
por: Calahorra, Leticia, et al.
Publicado: (2022)

Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets
por: Hjorth, Maria, et al.
Publicado: (2020)

Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients
por: Chiarini, Marco, et al.
Publicado: (2020)

No lack of regulatory B cells in patients with Multiple Sclerosis
por: Michel, Laure, et al.
Publicado: (2012)

Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
por: Vasileiadis, Georgios K., et al.
Publicado: (2018)

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
por: Lundy, Steven K., et al.
Publicado: (2016)

Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients – preliminary study
por: Rudnicka, Julia, et al.
Publicado: (2015)

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
por: Liu, Pen-Ju, et al.
Publicado: (2023)

Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets
por: Guo, Michael H., et al.
Publicado: (2022)

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015)

Distinct T cell signatures define subsets of patients with multiple sclerosis
por: Johnson, Mark C., et al.
Publicado: (2016)

Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
por: Verreycken, Janne, et al.
Publicado: (2022)

The Choroid Plexus Is Permissive for a Preactivated Antigen-Experienced Memory B-Cell Subset in Multiple Sclerosis
por: Haas, Jürgen, et al.
Publicado: (2021)

Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis
por: Gjelstrup, Mikkel Carstensen, et al.
Publicado: (2017)

Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis
por: Buckle, Guy, et al.
Publicado: (2020)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

Frequent somatic mosaicism in T lymphocyte subsets in individuals with and without multiple sclerosis
por: Van Horebeek, Lies, et al.
Publicado: (2022)

Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis
por: Gambichler, T, et al.
Publicado: (2010)

Association between body fat distribution and B-lymphocyte subsets in peripheral blood
por: Prechtl, Pia, et al.
Publicado: (2023)

BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth
por: Deng, Jiusheng, et al.
Publicado: (2016)

Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis
por: Guo, Shujun, et al.
Publicado: (2018)

Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
por: Gross, Catharina C., et al.
Publicado: (2015)

Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis
por: Ghadiri, Mahtab, et al.
Publicado: (2020)

Loss of IL-10 secretion by regulatory B lymphocytes in multiple sclerosis patients
por: Michel, Laure, et al.
Publicado: (2011)

Regulatory T cells in multiple sclerosis and myasthenia gravis
por: Danikowski, K. M., et al.
Publicado: (2017)

Subsets of regulatory T cells and their roles in allergy
por: Zhang, Huiyun, et al.
Publicado: (2014)

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
por: Fitzgerald, Kathryn C., et al.
Publicado: (2022)

DNMT3B-579G>T (rs1569686G>T) polymorphism and the risk of multiple sclerosis in a subset of Iranian population
por: Yazdanpanahi, Nasrin, et al.
Publicado: (2019)

Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus
por: El-Mokhtar, Mohamed A., et al.
Publicado: (2020)

Regulatory Role of B Cells and Its Subsets in Hepatitis E Virus Infection
por: Sharma, Meenal, et al.
Publicado: (2022)

Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren’s syndrome
por: Cornec, Divi, et al.
Publicado: (2014)

Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells
por: Zhang, Zijian, et al.
Publicado: (2018)

Regulatory Functions of Natural Killer Cells in Multiple Sclerosis
por: Gross, Catharina C., et al.
Publicado: (2016)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood
por: Hohmann, Christopher, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ck9pedjgkonpucnmt9e8irv4d8